Skip to Main Content
Contribute Try STAT+ Today

Covid-19 has underscored the critical role the biopharma industrial base plays in the U.S.’s national and economic security. As I write this, safe and effective Covid-19 vaccines that were developed in record time are protecting and saving lives and making it possible for people to return to the office, school, and travel — normal life, in other words.

In January 2018, STAT reporter Helen Branswell wrote a story that posed a worrisome question: “Who will answer the call in the next outbreak?” She recognized the risk to fragile partnerships between U.S. government agencies and the biopharmaceutical companies that had answered the call to a series of outbreaks, epidemics, and pandemics over a 15-year period, including West Nile, severe acute respiratory syndrome (SARS), the H1N1 pandemic, Middle East respiratory syndrome (MERS), H7N9 influenza, Ebola virus disease, and Zika.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment